MARKET

INGN

INGN

Inogen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

49.13
-1.04
-2.07%
Closed 16:00 01/27 EST
OPEN
49.80
PREV CLOSE
50.17
HIGH
50.79
LOW
48.54
VOLUME
224.24K
TURNOVER
--
52 WEEK HIGH
55.55
52 WEEK LOW
26.57
MARKET CAP
1.09B
P/E (TTM)
-509.1192
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
BRIEF-Inogen Announces CEO Transition
reuters.com · 1d ago
Inogen's Chief retires in February
Inogen (INGN) has appointed Nabil Shabshab as President, Chief Executive Officer and also o the Board of Directors, effective February 8, 2021.Mr. Shabshab will succeed Scott Wilkinson, who is retiring
Seekingalpha · 1d ago
Inogen Announces CEO Transition
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its...
BusinessWire - BZX · 1d ago
Inogen Names Nabil Shabshab CEO
MT Newswires · 1d ago
Inogen (INGN) Gets a Hold Rating from Needham
Needham analyst Michael Matson maintained a Hold rating on Inogen (INGN) today. The company's shares closed last Monday at $47.90. According to
SmarterAnalyst · 2d ago
BRIEF-Inogen Inc Says On January 22, Board Appointed Nabil Shabshab To Serve As President And Chief Executive Officer Of Company
reuters.com · 3d ago
49.1% Return Seen to Date on SmarTrend Inogen Inc Call (INGN)
SmarTrend identified an Uptrend for Inogen Inc (NASDAQ:INGN) on October 12th, 2020 at $31.36. In approximately 3 months, Inogen Inc has returned 49.10% as of today's recent price of $46.75.
Comtex SmarTrend(R) · 6d ago
Oxygen Bag Market Share 2021 Explosive Growth Analysis, Size, Top Key Players, Demand, Regional Trends and Forecasts to 2025
The Express Wire · 01/20 08:09
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of INGN. Analyze the recent business situations of Inogen through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average INGN stock price target is 41.75 with a high estimate of 60.00 and a low estimate of 30.00.
EPS
Institutional Holdings
Institutions: 299
Institutional Holdings: 23.90M
% Owned: 108.04%
Shares Outstanding: 22.12M
TypeInstitutionsShares
Increased
54
917.50K
New
44
-118.94K
Decreased
50
2.07M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-3.07%
Healthcare Equipment & Supplies
-2.98%
Key Executives
Chairman/Director
Heath Lukatch
President/Chief Executive Officer/Director
Scott Wilkinson
Chief Financial Officer/Executive Vice President - Finance/Treasurer/Secretary
Alison Bauerlein
Executive Vice President/Director of Sales
Arron Retterer
Executive Vice President/Director of Marketing
Byron Myers
Executive Vice President
Bart Sanford
Executive Vice President
Brenton Taylor
Independent Director
Benjamin Anderson-Ray
Independent Director
Scott Beardsley
Independent Director
R. Scott Greer
Independent Director
Raymond Huggenberger
Independent Director
Loren McFarland
Independent Director
Heather Rider
  • Dividends
  • Splits
  • Insider Activity
No Data
About INGN
Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Webull offers kinds of Inogen Inc stock information, including NASDAQ:INGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INGN stock methods without spending real money on the virtual paper trading platform.